EV/EBITDA
-5.58
-0.11-2.01%
Fri, 29 Nov 2024 20:51:08 GMT
Summary:
EyePoint Pharmaceuticals EV/EBITDA is currently -5.58, with a fall of -0.11 (-2.01%) during the most recent trading day. Over the past year, it has dropped by -4.55 (-441.75%). EYPT EV/EBITDA is now -108.49% below its all-time high of 65.72.EYPT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -2.0% |
| 1 m1 month | -2.0% |
| 3 m3 months | -20.0% |
| 6 m6 months | -38.1% |
| ytdytd | +55.1% |
| 1 y1 year | -441.8% |
| 5 y5 years | -20.8% |
EYPT EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -5.02 | -11.2% | -7.42 | +24.8% |
| 3 m | 3 months | -3.61 | -54.6% | -7.42 | +24.8% |
| 6 m | 6 months | -2.06 | -170.9% | -7.42 | +24.8% |
| 1 y | 1 year | -1.03 | -441.8% | -17.13 | +67.4% |
| 3 y | 3 years | -0.29 | -1824.1% | -17.13 | +67.4% |
| 5 y | 5 years | -0.29 | -1824.1% | -17.13 | +67.4% |
| alltime | all time | 65.72 | -108.5% | -4141 | +99.9% |
EyePoint Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -5.58(-55.1%) |
| 2023 | -12.42(+1625.0%) |
| 2022 | -0.72(-86.9%) |
| 2021 | -5.50(+69.2%) |
| 2020 | -3.25(-20.9%) |
| 2019 | -4.11(+123.4%) |
| 2018 | -1.84(+12.9%) |
| 2017 | -1.63(-37.5%) |
| 2016 | -2.61(-61.2%) |
| Date | Value |
|---|---|
| 2015 | -6.72(-183.7%) |
| 2014 | 8.03(-213.6%) |
| 2013 | -7.07(+794.9%) |
| 2012 | -0.79(+1.3%) |
| 2011 | -0.78(-104.4%) |
| 2009 | 17.73(<-9900.0%) |
| 2008 | -0.12(-163.2%) |
| 2007 | 0.19(-218.8%) |
| 2006 | -0.16 |
FAQ
- What is EyePoint Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for EyePoint Pharmaceuticals?
- What is EYPT EV/EBITDA year-to-date change?
- What is EyePoint Pharmaceuticals EV/EBITDA year-on-year change?
What is EyePoint Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of EYPT is -5.58
What is the all time high EV/EBITDA for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high EV/EBITDA is 65.72
What is EYPT EV/EBITDA year-to-date change?
EyePoint Pharmaceuticals EV/EBITDA has changed by +6.84 (+55.07%) since the beginning of the year
What is EyePoint Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, EYPT EV/EBITDA has changed by -4.55 (-441.75%)